Nguyen H. Tran, M.D.

  1. Oncologist

Publicaciones

  1. Tran NH, Kisiel J, Roberts LR. Using cell-free DNA for HCC surveillance and prognosis. JHEP Rep. 2021 Aug; 3 (4):100304 Epub 2021 May 10
    View PubMed
  2. Tran NH, Foster NR, Mahipal A, Byrne T, Hubbard J, Silva A, Mody K, Alberts S, Borad MJ. Phase IB study of sorafenib and evofosfamide in patients with advanced hepatocellular and renal cell carcinomas (NCCTG N1135, Alliance). Invest New Drugs. 2021 Mar 1 Epub 2021 Mar 01
    View PubMed
  3. Tran NH, Sahai V, Griffith KA, Nathan H, Kaza R, Cuneo KC, Shi J, Kim E, Sonnenday CJ, Cho CS, Lawrence TS, Zalupski MM. Phase II trial of neoadjuvant FOLFIRINOX and IMRT concurrent with FDR-gemcitabine in patients with borderline resectable pancreatic cancer. Int J Radiat Oncol Biol Phys. 2019.
  4. Payne SN, Maher ME, Tran NH, Van De Hey DR, Foley TM, Yueh AE, Leystra AA, Pasch CA, Jeffrey JJ, Clipson L, Matkowskyj KA, Deming DA. PIK3CA mutations can initiate pancreatic tumorigenesis and are targetable with PI3K inhibitors. Oncogenesis. 2015 Oct 5; 4:e169 Epub 2015 Oct 05
    View PubMed
  5. Tran NH, Cavalcante LL, Lubner SJ, Mulkerin DL, LoConte NK, Clipson L, Matkowskyj KA, Deming DA. Precision medicine in colorectal cancer: the molecular profile alters treatment strategies. Ther Adv Med Oncol. 2015 Sep; 7 (5):252-62
    View PubMed
  6. Tran N, Stapleton J, Zhang Y, Harlow S, Yang H, Moyer CA. Contraceptive practices of women visiting a gynecology clinic in Beijing, China. Int J Gynaecol Obstet. 2011 Jan; 112 (1):64-5 Epub 2010 Oct 18
    View PubMed
PST-20467935